NO20043794L - Benzensulfonamidderivater som antipsykotiske midler - Google Patents

Benzensulfonamidderivater som antipsykotiske midler

Info

Publication number: NO20043794L
Authority: NO; Norway
Prior art keywords: antipsychotic agents; benzenesulfonamide derivatives; benzenesulfonamide; derivatives; antipsychotic
Prior art date: 2002-02-13

Application number

NO20043794A

Other languages

English (en)

Inventor

David Gwyn Cooper

Steven Mark Bromidge

Christopher Norbert Johnson

Andrew Derrick Gribble

Andrew Hele Payne

Andrew P Lightfoot

David R Witty

Ian Thomson Forbes

Stephen Frederick Moss

Shahzad Sharooq Rahman

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-13

Filing date

2004-09-10

Publication date

2004-09-10

2002-02-13 Priority claimed from GB0203437A external-priority patent/GB0203437D0/en

2002-02-13 Priority claimed from GB0203438A external-priority patent/GB0203438D0/en

2002-02-28 Priority claimed from GB0204784A external-priority patent/GB0204784D0/en

2002-02-28 Priority claimed from GB0204758A external-priority patent/GB0204758D0/en

2002-05-30 Priority claimed from GB0212548A external-priority patent/GB0212548D0/en

2002-08-23 Priority claimed from GB0219711A external-priority patent/GB0219711D0/en

2002-10-21 Priority claimed from GB0224466A external-priority patent/GB0224466D0/en

2004-09-10 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-09-10 Publication of NO20043794L publication Critical patent/NO20043794L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

NO20043794A 2002-02-13 2004-09-10 Benzensulfonamidderivater som antipsykotiske midler NO20043794L (no)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
GB0203437A GB0203437D0 (en)	2002-02-13	2002-02-13	Novel compounds
GB0203438A GB0203438D0 (en)	2002-02-13	2002-02-13	Compounds
GB0204784A GB0204784D0 (en)	2002-02-28	2002-02-28	Compounds
GB0204758A GB0204758D0 (en)	2002-02-28	2002-02-28	Novel compounds
GB0212548A GB0212548D0 (en)	2002-05-30	2002-05-30	Novel compounds
GB0219711A GB0219711D0 (en)	2002-08-23	2002-08-23	Novel compounds
GB0224466A GB0224466D0 (en)	2002-10-21	2002-10-21	Compounds
PCT/EP2003/001545 WO2003068752A1 (en)	2002-02-13	2003-02-13	Benzenesulfonamide derivatives as antipsychotic agents

Publications (1)

Publication Number	Publication Date
NO20043794L true NO20043794L (no)	2004-09-10

Family

ID=27739513

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043794A NO20043794L (no)	2002-02-13	2004-09-10	Benzensulfonamidderivater som antipsykotiske midler

Country Status (14)

Country	Link
US (1)	US20050222124A1 (no)
EP (1)	EP1474399A1 (no)
JP (1)	JP2005526724A (no)
KR (1)	KR20040081201A (no)
CN (1)	CN1630642A (no)
AU (1)	AU2003215558A1 (no)
BR (1)	BR0307557A (no)
CA (1)	CA2475783A1 (no)
CO (1)	CO5611103A2 (no)
IS (1)	IS7388A (no)
MX (1)	MXPA04007920A (no)
NO (1)	NO20043794L (no)
PL (1)	PL371344A1 (no)
WO (1)	WO2003068752A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050085461A1 (en) *	2002-02-13	2005-04-21	Cooper David G.	Benzenesulfonamide derivatives
ATE323680T1 (de) *	2002-02-13	2006-05-15	Glaxo Group Ltd	7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
MY133587A (en)	2002-05-29	2007-11-30	Glaxo Group Ltd	Aromatic sulfones and their medical use
DE60305519T2 (de)	2002-10-07	2006-11-23	Glaxo Group Ltd., Greenford	Sulfonamidderivate als antipsychotische mittel
GB0321475D0 (en) *	2003-09-12	2003-10-15	Glaxo Group Ltd	Novel compounds
GB0327741D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327737D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327740D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compounds
GB0327738D0 (en) *	2003-11-28	2003-12-31	Glaxo Group Ltd	Novel compound
EP1694334B1 (en) *	2003-12-18	2011-10-19	Abbott GmbH & Co. KG	Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
US20050137186A1 (en) *	2003-12-18	2005-06-23	Abbott Gmbh & Co. Kg.	Tetrahydrobenzazepines and their use
AR051919A1 (es) *	2004-06-18	2007-02-21	Glaxo Group Ltd	Compuesto derivado de benzazepina, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimientos para preparar el compuesto
CN103073460B (zh) *	2004-10-14	2015-09-09	Abbvie德国有限责任两合公司	适用于治疗对于多巴胺d3受体的调节有反应的疾病的芳基磺酰基甲基或芳基磺酰胺取代的芳族化合物
FR2878524B1 (fr) *	2004-12-01	2007-01-19	Bioprojet Soc Civ Ile	Nouveaux derives d'arylpiperazine
WO2006062481A1 (en) *	2004-12-09	2006-06-15	Biovitrum Ab	New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
EP1837332A1 (en) *	2006-03-23	2007-09-26	Laboratorios Del Dr. Esteve, S.A.	Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
EP2314577A1 (en) *	2009-10-16	2011-04-27	Almirall, S.A.	Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
CN103145619A (zh) *	2012-06-15	2013-06-12	史慎德	7-氯-6-苯磺酰氨基-2,3,4,5-四氢-1H-苯并[d]氮杂*的制备
RS64027B1 (sr) *	2016-03-22	2023-03-31	Helsinn Healthcare Sa	Benzenesulfonil-asimetrične uree i njihove medicinske upotrebe
CA3196278A1 (en) *	2020-09-23	2022-03-31	St. Jude Children's Research Hospital, Inc.	Substituted n-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ2376A1 (fr) *	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
TR200000073T2 (tr) *	1997-07-11	2000-06-21	Smithkline Beecham P.L.C.	5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi
GB9801392D0 (en) *	1998-01-22	1998-03-18	Smithkline Beecham Plc	Novel compounds
GB9803411D0 (en) *	1998-02-18	1998-04-15	Smithkline Beecham Plc	Novel compounds
GB9926302D0 (en) *	1999-11-05	2000-01-12	Smithkline Beecham Plc	Novel compounds
US20050085461A1 (en) *	2002-02-13	2005-04-21	Cooper David G.	Benzenesulfonamide derivatives
ATE323680T1 (de) *	2002-02-13	2006-05-15	Glaxo Group Ltd	7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen

2003
- 2003-02-13 JP JP2003567883A patent/JP2005526724A/ja active Pending
- 2003-02-13 EP EP03739495A patent/EP1474399A1/en not_active Withdrawn
- 2003-02-13 CN CNA038037467A patent/CN1630642A/zh active Pending
- 2003-02-13 BR BR0307557-5A patent/BR0307557A/pt not_active IP Right Cessation
- 2003-02-13 PL PL03371344A patent/PL371344A1/xx not_active Application Discontinuation
- 2003-02-13 AU AU2003215558A patent/AU2003215558A1/en not_active Abandoned
- 2003-02-13 CA CA002475783A patent/CA2475783A1/en not_active Abandoned
- 2003-02-13 US US10/504,111 patent/US20050222124A1/en not_active Abandoned
- 2003-02-13 KR KR10-2004-7012464A patent/KR20040081201A/ko not_active Application Discontinuation
- 2003-02-13 MX MXPA04007920A patent/MXPA04007920A/es unknown
- 2003-02-13 WO PCT/EP2003/001545 patent/WO2003068752A1/en active Application Filing
2004
- 2004-08-06 IS IS7388A patent/IS7388A/is unknown
- 2004-08-13 CO CO04079408A patent/CO5611103A2/es not_active Application Discontinuation
- 2004-09-10 NO NO20043794A patent/NO20043794L/no unknown

Also Published As

Publication number	Publication date
CA2475783A1 (en)	2003-08-21
IS7388A (is)	2004-08-06
BR0307557A (pt)	2005-01-04
JP2005526724A (ja)	2005-09-08
EP1474399A1 (en)	2004-11-10
CN1630642A (zh)	2005-06-22
MXPA04007920A (es)	2004-11-26
WO2003068752A1 (en)	2003-08-21
PL371344A1 (en)	2005-06-13
KR20040081201A (ko)	2004-09-20
US20050222124A1 (en)	2005-10-06
CO5611103A2 (es)	2006-02-28
AU2003215558A1 (en)	2003-09-04

Publication	Publication Date	Title
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
NO20044325L (no)	2004-12-16	4-anilinokinazolinderivater som antiproliferative midler
NO20043794L (no)	2004-09-10	Benzensulfonamidderivater som antipsykotiske midler
DK1663996T3 (da)	2012-10-01	(Thio)carbamoylcyclohexanderivater som D3/D2-receptorantagonister
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
DK1397364T3 (da)	2007-11-26	Hidtil ukendte pyrrolderivater som farmaceutiske midler
ATE478870T1 (de)	2010-09-15	Spiroindolinpiperidinderivate
DK1556385T3 (da)	2010-06-14	Heterocyclocarboxamid-derivater
ATE450506T1 (de)	2009-12-15	Indol-3-schwefelderivate
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
NO20052884D0 (no)	2005-06-14	Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
IS7720A (is)	2005-03-01	Píperidín-N-oxíð-afleiður
ATE438644T1 (de)	2009-08-15	Chinazolinderivate
DK1578750T3 (da)	2008-03-17	Kationiske porphyrinderivater som antibakterielle midler
DK1474408T3 (da)	2012-06-25	N-Phenyl-2-pyrimidinaminderivater
DK1492785T3 (da)	2009-03-02	2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
NO20051236L (no)	2005-04-08	Heterobiarylderivater som matriksmetalloproteinaseinhibitorer
NO20033618L (no)	2003-10-15	Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
DK1478629T3 (da)	2007-01-29	N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
DK1442030T3 (da)	2006-12-27	Thiopen- og thiazolsulfonamider som antineoplastiske midler
NO20044998L (no)	2005-01-18	Tioksantinderivater som myeloperoksidaseinhibitorer
DK1456206T3 (da)	2008-09-08	Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
ATE459598T1 (de)	2010-03-15	Sulfonamidderivate
DK1455779T3 (da)	2006-10-30	Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander